Article on Incorporating future medical costs: Impact on #costeffectiveness of #sepsis intervention in #cancer patients show it’s impact varies across cancer types and longer life expectancies did not necessarily result in greater lifetime healthcare costs https://t.co/uWjgJGqjTB
New Job Listing on the AHES website:
Research Fellow/Senior Research Fellow (HTA), The University of Melbourne
For more information visit: Jobs - Australian Health Economics Society (https://t.co/3m96czwDb6)
Research Assistant/Research Fellow, Health Technology Assessment role at Melbourne Health Technology and Value Assessment Collaboration (M-VAC) - Melbourne Health Economics, University of Melbourne
https://t.co/K6Y5BTXXXh
Applications close 4th March.
New Job Listing on the AHES website:
PhD opportunity - The University of Melbourne @HEU_unimelb
For more information, visit our AHES website:
https://t.co/AxEtd6lEaa
#HTAiAdelaide2023 Grateful for the opportunity to present an economic evaluation alongside the PIPPIN trial @NCICancer which finds FDG-PET/CT a cost-effective diagnostic tool for neutropenia fever in high risk cancer patients @HEU_unimelb@HealthPolicyUoM
Andrew Wilson #HTAiAdelaide2023 indicated that compared to other OECD countries, Australia falls behind in access and equity of health technologies. What can we do better?
Fascinating work showcasing living network meta-analysis to consolidate evidence from multiple clinical trials with different treatment regiments for prostrate cancer. Care is needed to account for heterogeneity #HTAiAdelaide2023
Time to consider reference models for HTA? Interesting talk by Hossein Afzali. Structural uncertainty often not assessed. Empirical evidence has shown that it can have greater impact on CEA results compared to parameter uncertainty. #HTAiAdelaide2023#HealthEconomics
Balancing speed and rigor. Fascinating debate from multiple perspectives on how to get novel innovative tech to patients sooner #HTAiAdelaide2023 Some key considerations- accounting for spillover effects to careers, use of RWE
Excited to be attending #HTAi2023Adelaide this week starting with a workshop on hospital-based HTA. Lots of interesting insights shared by key experts in this area particularly around importance of stakeholder buy-in, engaging the right clinicians to collaborate with.
📣 New paper alert! Recruitment is no doubt a challenge for any clinical trial. In this paper we developed an economic model to show the trade-offs between time and cost, or both, when recruitment is lower than anticipated. Spoiler alert. It’s costly! https://t.co/7WHi7n3OJq